Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients

British Journal of Haematology

Volumn 109, Issue 1, 2000, Pages 46-53

  Besostri, Barbara ^a   Beggiato, Eloise ^a   Bianchi, Alberto ^a   Mariani, Sara ^a   Coscia, Marta ^a   Peola, Silvia ^a   Foglietta, Myriam ^a   Boccadoro, Mario ^a   Pileri, Alessandro ^a   Moretta, Lorenzo ^b,c   Massaia, Massimo ^a,d  

^a MOLINETTE HOSPITAL   (Italy)

^b CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Dipto di Med e Oncol Sperimentale Div Universitaria di Ematologia   (Italy)

Author keywords

CD94; Cytotoxicity; Inhibitory receptors; Myeloma; T lymphocytes

Indexed keywords

CD94 ANTIGEN; CELL RECEPTOR; T LYMPHOCYTE RECEPTOR;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD45; ANTIGENS, CD94; CASE-CONTROL STUDIES; CELL DIVISION; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MULTIPLE MYELOMA;

EID: 0034110571     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01981.x     Document Type: Article

References (34)

1. Bakker, A.B., Phillips, J.H., Figdor, C.G. & Lanier, L.L. (1998) Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gd T cells and antigen-specific CTL. Journal of Immunology 160, 5239-5245.
2. Bertone. S., Schiavetti, F., Bellomo, R., Vitale, C., Ponte, M., Moretta, L. & Mingari, M.C. (1999) Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. European Journal of Immunology, 29, 23-29.
3. Bianchi, A., Mariani, S., Beggiato, E., Borrione, P., Peola, S., Boccadoro, M., Pileri, A. & Massaia, M. (1997) Distribution of T-cell signalling molecules in human myeloma. British Journal of Haematology, 97, 815-820.
4. Borrione, P., Beggiato, E., Montacchini, L., Pileri, A., Bianchi, A. & Massaia, M. (1996) Clinical and immunological studies in advanced cancer patients sequentially treated with OKT3 and IL-2. Leukemia and Lymphoma, 21, 325-330.
5. Brand, V.M., Allan, D.S., O'Callaghan, C.A., Soderstrom, K., D'Andrea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H., Lanier, L.L. & McMichael, A.J. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature, 391, 795-799.
6. Cantoni, C., Biassoni, R., Pende, D., Sivori, S., Accame, L., Pareti, L., Semenzato, G., Moretta, L., Moretta, A. & Bottino, C. (1998) The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. European Journal of Immunology, 28, 327-338.
7. De Maria, A., Ferraris, A., Guastella, M., Pilia, S., Cantoni, C., Polero, L., Mingari, M.C., Bassetti, D., Fauci, A.S. & Moretta, L. (1997) Expression of HLA class 1-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolylic functions. Proceedings of the National Academy of Sciences of the USA, 94, 10285-10288.
8. Dianzani, U., Pileri, A., Boccadoro, M., Palumbo, A., Pioppo, P., Bianchi. A., Camponi, A., Battaglio, S. & Massaia, M. (1988) Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. Blood, 72, 1064-1068.
9. Duric, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting features, response to treatment and survival. Cancer, 36, 842-854.
10. Fisch, P., Meuer, E., Pende, D., Rothenfuber, S., Viale, O., Kock, S.,s Ferrone, S., Fradelizi, D., Klein, G., Moretta, L., Rammensee, H.G., Boon, T., Coulie, P.G. & Van der Bruggen, P. (1997) Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vg9/Vd2 T cells in tumor immunity. European Journal of Immunology, 27, 3368-3379.
11. Ikeda, H., Lethe, B., Lehmann, F., Van Baren, N., Baurain, J.F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T. & Coulie, P.G. (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity, 6, 199-208.
12. Leach, D.R., Krummel, M.F. & Allison, J.P. (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science, 271, 1734-1736.
13. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M. & Geraghty, D.E. (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proceedings of the National Academy of Sciences of the USA, 95, 5199-5204.
14. Lopez-Botet, M., Perez-Villar, J.J., Carretero, M., Rodriguez, A., Melero, I., Bellon, T., Llano, M. & Navarro, F. (1997) Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class 1 molecules. Immunological Review. 155, 165-174.
15. Mandelboim, O., Davis, D.M., Reyburn, H.T., Vales-Gomez, M., Sheu, E.G., Pazmany, L. & Strominger, J.L. (1996) Enhancement of class II-restricted T cell responses by co-stimulatory NK receptors for class I MHC proteins. Science, 274, 2097-2100.
16. Massaia, M., Dianzani, U., Bianchi, A., Camponi, A., Boccadoro, M. & Pileri, A. (1988) Defective generation of alloreadive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies. Clinical Experimental Immunology, 75, 214-218
17. Massaia, M., Bianchi, A., Dianzani, U., Camponi, A., Attisano, C., Boccadoro, M. & Pileri, A. (1990) Defective interleukin-2 induction of lymphokine-activated killer (LAK) activity in peripheral blood T lymphocytes of patients with monoclonal gammopathies. Clinical Experimental Immunology, 79, 100-104.
18. Massaia, M., Bianchi, A., Altisano, C., Peola, S., Redoglia, V., Dianzani, U. & Pileri, A. (1991) Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex. Blood, 78, 1770-1780.
19. Massaia, M., Attisano, C., Peola, S., Montacchini, L., Omedè, P., Corradini, P., Ferrero, D., Boccadoro, M., Bianchi, A. & Pileri, A. (1993) Rapid generation of anti-plasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells. Blood, 82, 1787-1797.
20. Massaia, M., Borrione, P., Attisano, C., Barral, P., Beggiato, E., Montacchini, L., Bianchi, A., Boccadoro, M. & Pileri, A. (1995) Dysregulated Fas and bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood, 85, 3679-3687.
21. Mingari, M.C., Vitale, C., Schiavetti, F., Cambiaggi, A., Bertone, S., Zunino, A. & Ponte, M. (1996a) HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. Chemistry Immunology, 64, 135-145.
22. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proceedings of the National Academy of Sciences of the USA, 93, 12433-12438.
23. + T cells. Proceedings of the National Academy of Sciences of the USA, 95, 1172-1177.
24. Mingari, M.C., Moretta, A. & Moretta, L. (1998b) Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunology Today, 19, 153-157.
25. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. Journal of Experimental Medicine, 172, 1589-1598.
26. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M.C. & Moretta, L. (1996) Receptors for HLA-class I-molecules in human natural killer cells. Annual Review of Immunology, 14, 619-648.
27. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M.C. & Moretta, L. (1997) Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunological Review, 155, 105-117.
28. Omedè, P., Boccadoro, M., Gallone, G., Frieri, R., Battaglio, S., Redoglia, V. & Pileri, A. (1990) Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. Blood, 76, 1375-1379.
29. 2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy. Cancer Immunological Immunotherapy, 34, 157-162.
30. Pardoll, D. (1996) Releasing the brakes on antitumor immune response. Science, 271, 1691.
31. Pende, D., Sivori, S., Accame, L., Pareti, L., Falco, M., Geraghty, D., Le Bouteiller, P., Moretta, L. & Moretta, A. (1997) HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. European Journal of Immunology, 27, 1875-1880.
32. Sivori, S., Vitale, M., Bottino, C., Marcenaro, E., Sanseverino, L., Parolini, S., Moretta, L. & Moretta, A. (1996) CD94 functions as a natural killer cell inhibitory receptor for different HLA class 1 alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. European Journal of Immunology, 26, 2487-2492.
33. Speiser, D.E., Valmori, D., Rimoldi, D., Pittet, M.J., Lienard, D., Cerundolo, V., MacDonald, H.R., Cerottini, J.C. & Romero, P. (1999) CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. European Journal of Immunology, 29, 1990-1999.
34. Wen, Y.J., Ling, M. & Lim, S.H. (1998) Immunogenicity and cross-reactivity with idiotypic IgA of VH CDR3 peptide in multiple myeloma. British Journal of Haematology, 100, 464-468.